TrademarkOpen
Search / United States / 97696609

Heads up: we show every live trademark, plus inactive ones from the last 5 years, in the United States, Singapore, Canada, Australia and France. India is looked up live when you search, so it is not a saved copy of every mark, and it can be busy some days. Data is only as fresh as each country publishes it, and some countries aren’t included yet, so a brand can be registered even if it doesn’t show here. Always check the official record before you use a name. This is not legal advice.

🇺🇸 United States · Trademark / Service Mark

LOOP GENOMICS

Allowed — statement of use stage
Fourth Extension - Granted
Used for: Reagents for scientific and research use; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA…
Show more

Class 1: Reagents for scientific and research use; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for basic scientific research and for pharmaceutical, industrial, and medical research purposes
Class 5: Reagents for medical or veterinary purposes; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for medical diagnostic purposes
Class 42: DNA and RNA analysis services for scientific research purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for scientific and medical research purposes; software as a service services, namely, providing temporary use of non-downloadable software for bioinformatic analysis of sequencing data
Class 44: DNA and RNA analysis services for medical diagnostic purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application-specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for medical diagnostic purposes

Class 1 – ChemicalsClass 5 – Pharmaceuticals & supplementsClass 42 – Technology & SaaSClass 44 – Medical & beauty services

Status timeline

  1. 2 Dec 2022
    Application filed
    New Application Entered
  2. 7 Sep 2023
    Assigned to an examining attorney
    Assigned To Examiner
  3. 8 Sep 2023
    Office action issued
    Non-Final Action Written
  4. 2 Nov 2023
    Response to office action filed
    Teas Response To Office Action Received
  5. 6 Nov 2023
    Approved for publication
    Approved For Pub - Principal Register
  6. 12 Dec 2023
    Published for opposition
    Published For Opposition
  7. 6 Feb 2024
    Notice of allowance issued — statement of use required
    Noa Mailed - Sou Required From Applicant
  8. 1 Jul 2024
    Statement-of-use extension 1 granted
    Sou Extension 1 Granted
  9. 22 Jan 2025
    Statement-of-use extension 2 granted
    Sou Extension 2 Granted
  10. 4 Aug 2025
    Statement-of-use extension 3 granted
    Sou Extension 3 Granted
All 31 events
2026-07-31Sou Teas Extension Received
2026-02-03Notice Of Approval Of Extension Request E-Mailed
2026-02-02Sou Teas Extension Received
2026-02-02Sou Extension 4 Filed
2026-02-02Sou Extension 4 Granted
2025-08-05Notice Of Approval Of Extension Request E-Mailed
2025-08-04Sou Teas Extension Received
2025-08-04Sou Extension 3 Filed
2025-08-04Sou Extension 3 Granted
2025-03-03Notice Of Approval Of Extension Request E-Mailed
2025-01-22Sou Extension 2 Granted
2025-01-21Sou Teas Extension Received
2025-01-21Sou Extension 2 Filed
2024-07-01Sou Teas Extension Received
2024-07-01Sou Extension 1 Filed
2024-07-01Sou Extension 1 Granted
2024-07-01Notice Of Approval Of Extension Request E-Mailed
2024-02-06Noa Mailed - Sou Required From Applicant
2023-12-12Published For Opposition
2023-12-12Official Gazette Publication Confirmation E-Mailed
2023-11-22Notification Of Notice Of Publication E-Mailed
2023-11-06Approved For Pub - Principal Register
2023-11-03Teas/Email Correspondence Entered
2023-11-02Teas Response To Office Action Received
2023-11-02Correspondence Received In Law Office
2023-09-08Non-Final Action Written
2023-09-08Non-Final Action E-Mailed
2023-09-08Notification Of Non-Final Action E-Mailed
2023-09-07Assigned To Examiner
2022-12-22New Application Office Supplied Data Entered
2022-12-02New Application Entered

Goods & services by class

Class 1 Chemicals

Reagents for scientific and research use; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for basic scientific research and for pharmaceutical, industrial, and medical research purposes

Class 5 Pharmaceuticals & supplements

Reagents for medical or veterinary purposes; reagent kits comprising DNA polymerases, RNA polymerases, DNA nucleases, RNA nucleases, DNA ligases, RNA ligases, other enzymes, primers, oligonucleotides, modified oligonucleotides, nucleotides and buffers and assays for preparing DNA and RNA samples for next generation sequencing (NGS) for medical diagnostic purposes

Class 42 Technology & SaaS

DNA and RNA analysis services for scientific research purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for scientific and medical research purposes; software as a service services, namely, providing temporary use of non-downloadable software for bioinformatic analysis of sequencing data

Class 44 Medical & beauty services

DNA and RNA analysis services for medical diagnostic purposes, namely, bioinformatic analysis of next generation sequencing data for transforming short read sequencing data into long-read sequencing data; bioinformatic data analysis of synthetic long-read sequencing data in an application-specific manner, namely, profiling microbiomes, cancer samples, and other human samples requiring long-read sequencing, for medical diagnostic purposes

Owner details

See the official record for contact details. View official record →

Source & freshness

Source: the official United States trademark register. This record was last updated on 31 Jul 2026; the index was built on 20 Nov 2026 and covers data through 31 Aug 2026. View official record → If the two differ, the official record is correct.